Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
Sander V. Haijma,Neeltje E.M. van Haren,Wiepke Cahn,P. Cédric M. P. Koolschijn,Hilleke E. Hulshoff Pol,René S. Kahn +5 more
Reads0
Chats0
TLDR
Brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.Abstract:
Although structural brain alterations in schizophrenia have been demonstrated extensively, their quantitative distribution has not been studied over the last 14 years despite advances in neuroimaging. Moreover, a volumetric meta-analysis has not been conducted in antipsychotic-naive patients. Therefore, meta-analysis on cross-sectional volumetric brain alterations in both medicated and antipsychotic-naive patients was conducted. Three hundred seventeen studies published from September 1, 1998 to January 1, 2012 comprising over 9000 patients were selected for meta-analysis, including 33 studies in antipsychotic-naive patients. In addition to effect sizes, potential modifying factors such as duration of illness, sex composition, current antipsychotic dose, and intelligence quotient matching status of participants were extracted where available. In the sample of medicated schizophrenia patients (n = 8327), intracranial and total brain volume was significantly decreased by 2.0% (effect size d = -0.17) and 2.6% (d = -0.30), respectively. Largest effect sizes were observed for gray matter structures, with effect sizes ranging from -0.22 to -0.58. In the sample of antipsychotic-naive patients (n = 771), volume reductions in caudate nucleus (d = -0.38) and thalamus (d = -0.68) were more pronounced than in medicated patients. White matter volume was decreased to a similar extent in both groups, while gray matter loss was less extensive in antipsychotic-naive patients. Gray matter reduction was associated with longer duration of illness and higher dose of antipsychotic medication at time of scanning. Therefore, brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.read more
Citations
More filters
Journal ArticleDOI
Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder.
Carlos Schönfeldt-Lecuona,Thomas Kregel,Arno Schmidt,Jan Kassubek,Jens Dreyhaupt,Roland W. Freudenmann,Bernhard J. Connemann,Maximilian Gahr,Elmar H. Pinkhardt +8 more
TL;DR: The authors' OCT measurements demonstrate reduced single retinal layer thickness in patients with SSD, providing further evidence that structural changes seen in the brain of patients are also observable in the retina, potentially allowing further insights into the different components of the nervous system that are altered in this highly etiologically complex disorder.
Journal ArticleDOI
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients.
Roberto Roiz-Santiañez,Rosa Ayesa-Arriola,Diana Tordesillas-Gutiérrez,V. Ortiz-García de la Foz,Rocío Pérez-Iglesias,Angel Pazos,Elena Sánchez,Benedicto Crespo-Facorro +7 more
TL;DR: Brain volume abnormalities that have been consistently observed at the onset of non-affective psychosis may not inevitably progress, at least over the first years of the illness.
Journal ArticleDOI
Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia.
Leslie G. Nucifora,Matthew L. MacDonald,Brian J. Lee,Matthew E. Peters,Alexis L. Norris,Alexis L. Norris,Benjamin C. Orsburn,Kun Yang,Kelly Gleason,Russell L. Margolis,Jonathan Pevsner,Jonathan Pevsner,Carol A. Tamminga,Robert A. Sweet,Christopher A. Ross,Akira Sawa,Frederick C. Nucifora +16 more
TL;DR: Determining the molecular mechanism of this subtype of schizophrenia could lead to a better understanding of the pathways underlying the clinical phenotype in some patients with major mental illness as well as to improved nosology and identification of novel therapeutic targets.
Journal ArticleDOI
Reduced paralimbic system gray matter volume in schizophrenia: Correlations with clinical variables, symptomatology and cognitive function
Jinmin Liao,Hao Yan,Qi Liu,Jun Yan,Lanlan Zhang,Sisi Jiang,Xiao Zhang,Zheng Dong,Wen Yang,Liwei Cai,Huining Guo,Yan Wang,Zimeng Li,Lin Tian,Dai Zhang,Dai Zhang,Fei Wang,Fei Wang +17 more
TL;DR: GMVs in the paralimbic system were significantly reduced in schizophrenia, and these abnormalities were correlated with clinical variables, symptomatology and cognitive function, which suggest theParalimbics system plays an important role in the pathophysiology of schizophrenia.
Journal ArticleDOI
Cortical thinning and caudate abnormalities in first episode psychosis and their association with clinical outcome
Cathy Scanlon,Heike Anderson-Schmidt,Liam Kilmartin,Shane McInerney,Joanne Kenney,John McFarland,Mairead Waldron,Srinath Ambati,Anna Fullard,Sam Logan,Brian Hallahan,Gareth J. Barker,Mark A. Elliott,Peter McCarthy,Dara M. Cannon,Colm McDonald +15 more
TL;DR: In this article, the structural integrity of grey matter in first-episode psychosis patients and assess whether these relate to patient clinical and functional outcome at 3-year follow-up was investigated.
References
More filters
Book
Statistical Power Analysis for the Behavioral Sciences
TL;DR: The concepts of power analysis are discussed in this paper, where Chi-square Tests for Goodness of Fit and Contingency Tables, t-Test for Means, and Sign Test are used.
Journal ArticleDOI
Measuring inconsistency in meta-analyses
TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI
Meta-Analysis of Regional Brain Volumes in Schizophrenia
Ian C. Wright,Sophia Rabe-Hesketh,Peter W.R. Woodruff,Anthony S. David,Robin M. Murray,Edward T. Bullmore +5 more
TL;DR: In this article, the authors conducted a systematic search for structural magnetic resonance imaging (MRI) studies of patients with schizophrenia that reported volume measurements of selected cortical, subcortical, and ventricular regions in relation to comparison groups.
Journal ArticleDOI
Cerebral ventricular size and cognitive impairment in chronic schizophrenia
TL;DR: By comparison with age-matched controls in employment, 17 institutionalised schizophrenic patients were shown by computerised axial tomography of the brain to have increased cerebral ventricular size.
Journal ArticleDOI
Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers
Eric Courchesne,Heather J. Chisum,Jeanne Townsend,Angilene Cowles,James Covington,Brian Egaas,Mark Harwood,Stuart Hinds,G A Press +8 more
TL;DR: In this article, the authors quantitatively quantitate neuroanatomic parameters in healthy volunteers and compare the values with normative values from postmortem studies, using MRI images of 116 volunteers aged 19 months to 80 years.
Related Papers (5)
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium
T.G.M. van Erp,Derrek P. Hibar,Jerod M. Rasmussen,David C. Glahn,Godfrey D. Pearlson,Ole A. Andreassen,Ingrid Agartz,Ingrid Agartz,Lars T. Westlye,Lars T. Westlye,Unn K. Haukvik,Anders M. Dale,Ingrid Melle,Cecilie B. Hartberg,Oliver Gruber,Bernd Kraemer,David Zilles,Gary Donohoe,Gary Donohoe,Sinead Kelly,Sinead Kelly,Colm McDonald,Derek W. Morris,Derek W. Morris,Dara M. Cannon,Aiden Corvin,Marise W. J. Machielsen,Laura Koenders,L. de Haan,Dick J. Veltman,Theodore D. Satterthwaite,Daniel H. Wolf,R.C. Gur,R.E. Gur,Steven G. Potkin,Daniel H. Mathalon,Daniel H. Mathalon,Bryon A. Mueller,Adrian Preda,Fabio Macciardi,Stefan Ehrlich,Stefan Ehrlich,Esther Walton,Johanna Hass,Vince D. Calhoun,HJ Bockholt,Scott R. Sponheim,Jody M. Shoemaker,N.E.M. van Haren,Hilleke E. Hulshoff Pol,Roel A. Ophoff,Roel A. Ophoff,René S. Kahn,Roberto Roiz-Santiañez,Benedicto Crespo-Facorro,Lei Wang,Kathryn I. Alpert,Erik G. Jönsson,Erik G. Jönsson,Rali Dimitrova,Catherine Bois,Heather C. Whalley,Andrew M. McIntosh,Stephen M. Lawrie,Ryota Hashimoto,Paul M. Thompson,Jessica A. Turner +66 more
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke,Stephan Ripke,Benjamin M. Neale,Benjamin M. Neale,Aiden Corvin,James T.R. Walters,Kai-How Farh,Peter Holmans,Phil Lee,Phil Lee,Brendan Bulik-Sullivan,Brendan Bulik-Sullivan,David A. Collier,David A. Collier,Hailiang Huang,Hailiang Huang,Tune H. Pers,Tune H. Pers,Tune H. Pers,Ingrid Agartz,Ingrid Agartz,Esben Agerbo,Esben Agerbo,Margot Albus,Madeline Alexander,Farooq Amin,Silviu Alin Bacanu,Martin Begemann,Richard A. Belliveau,Judit Bene,Sarah E. Bergen,Sarah E. Bergen,Elizabeth Bevilacqua,Tim B. Bigdeli,Donald W. Black,Richard Bruggeman,Nancy G. Buccola,Randy L. Buckner,William Byerley,Wiepke Cahn,Guiqing Cai,Dominique Campion,Rita M. Cantor,Vaughan J. Carr,Noa Carrera,Stanley V. Catts,Kimberly Chambert,Raymond C.K. Chan,Ronald Y.L. Chen,Eric Y.H. Chen,Wei Cheng,Eric F.C. Cheung,Siow Ann Chong,C. Robert Cloninger,David Cohen,Nadine Cohen,Paul Cormican,Nicholas John Craddock,James J. Crowley,David Curtis,David Curtis,Michael Davidson,Kenneth L. Davis,Franziska Degenhardt,Jurgen Del Favero,Ditte Demontis,Ditte Demontis,Dimitris Dikeos,Timothy G. Dinan,Srdjan Djurovic,Gary Donohoe,Gary Donohoe,Elodie Drapeau,Jubao Duan,Frank Dudbridge,Naser Durmishi,Peter Eichhammer,Johan G. Eriksson,Johan G. Eriksson,Valentina Escott-Price,Laurent Essioux,Ayman H. Fanous,Martilias S. Farrell,Josef Frank,Lude Franke,Robert Freedman,Nelson B. Freimer,Marion Friedl,Joseph I. Friedman,Menachem Fromer,Menachem Fromer,Menachem Fromer,Giulio Genovese,Lyudmila Georgieva,Ina Giegling,Ina Giegling,Paola Giusti-Rodríguez,Stephanie Godard,Jacqueline I. Goldstein,Jacqueline I. Goldstein,Vera Golimbet,Srihari Gopal,Jacob Gratten,Lieuwe de Haan,Christian Hammer,Marian L. Hamshere,Mark Hansen,Thomas Hansen,Vahram Haroutunian,Vahram Haroutunian,Annette M. Hartmann,Frans Henskens,Stefan Herms,Stefan Herms,Joel N. Hirschhorn,Joel N. Hirschhorn,Per Hoffmann,Per Hoffmann,A. Hofman,Mads V. Hollegaard,David M. Hougaard,Masashi Ikeda,Inge Joa,Antonio Julià,René S. Kahn,Luba Kalaydjieva,Sena Karachanak-Yankova,Juha Karjalainen,David J. Kavanagh,Matthew C. Keller,James L. Kennedy,Andrey Khrunin,Yunjung Kim,Janis Klovins,James A. Knowles,Bettina Konte,Vaidutis Kučinskas,Zita Ausrele Kucinskiene,Hana Kuzelova-Ptackova,Anna K. Kähler,Claudine Laurent,Jimmy Lee Chee Keong,S. Hong Lee,Sophie E. Legge,Bernard Lerer,Miaoxin Li,Tao Li,Kung-Yee Liang,Jeffrey A. Lieberman,Svetlana A. Limborska,Carmel M. Loughland,Jan Lubinski,Jouko Lönnqvist,Milan Macek,Patrik K. E. Magnusson,Brion S. Maher,Wolfgang Maier,J. Mallet,Sara Marsal,Manuel Mattheisen,Manuel Mattheisen,Manuel Mattheisen,Morten Mattingsdal,Robert W. McCarley,Colm McDonald,Andrew M. McIntosh,Sandra Meier,Carin J. Meijer,Béla Melegh,Ingrid Melle,Raquelle I. Mesholam-Gately,Andres Metspalu,Patricia T. Michie,Lili Milani,Vihra Milanova,Younes Mokrab,Derek W. Morris,Derek W. Morris,Ole Mors,Ole Mors,Kieran C. Murphy,Robin M. Murray,Inez Myin-Germeys,Bertram Mueller-Myhsok,Mari Nelis,Igor Nenadic,Deborah A. Nertney,Gerald Nestadt,Kristin K. Nicodemus,Liene Nikitina-Zake,Laura Nisenbaum,Annelie Nordin,Eadbhard O'Callaghan,Colm O'Dushlaine,F. Anthony O'Neill,Sang-Yun Oh,Ann Olincy,Line Olsen,Jim van Os,Jim van Os,Christos Pantelis,George N. Papadimitriou,Sergi Papiol,Elena Parkhomenko,Michele T. Pato,Tiina Paunio,Tiina Paunio,Milica Pejovic-Milovancevic,Diana O. Perkins,Olli Pietiläinen,Olli Pietiläinen,Jonathan Pimm,Andrew Pocklington,John Powell,Alkes L. Price,Alkes L. Price,Ann E. Pulver,Shaun Purcell,Digby Quested,Henrik B. Rasmussen,Abraham Reichenberg,Mark Reimers,Alexander Richards,Joshua L. Roffman,Panos Roussos,Douglas M. Ruderfer,Douglas M. Ruderfer,Veikko Salomaa,Alan R. Sanders,Ulrich Schall,Christian R. Schubert,Thomas G. Schulze,Thomas G. Schulze,Sibylle G. Schwab,Edward M. Scolnick,Rodney J. Scott,Larry J. Seidman,Jianxin Shi,Engilbert Sigurdsson,Teimuraz Silagadze,Jeremy M. Silverman,Jeremy M. Silverman,Kang Sim,Petr Slominsky,Jordan W. Smoller,Jordan W. Smoller,Hon-Cheong So,Chris C. A. Spencer,Eli A. Stahl,Eli A. Stahl,Hreinn Stefansson,Stacy Steinberg,Elisabeth Stögmann,Richard E. Straub,Eric Strengman,Jana Strohmaier,T. Scott Stroup,Mythily Subramaniam,Jaana Suvisaari,Dragan M. Svrakic,Jin P. Szatkiewicz,Erik Söderman,Srinivas Thirumalai,Draga Toncheva,Sarah Tosato,Juha Veijola,John L. Waddington,Dermot Walsh,Dai Wang,Qiang Wang,Bradley T. Webb,Mark Weiser,Dieter B. Wildenauer,Nigel Williams,Stephanie Williams,Stephanie H. Witt,Aaron R. Wolen,Emily H. M. Wong,Brandon Wormley,Hualin Simon Xi,Clement C. Zai,Xuebin Zheng,Fritz Zimprich,Naomi R. Wray,Kari Stefansson,Peter M. Visscher,Rolf Adolfsson,Ole A. Andreassen,Douglas Blackwood,Elvira Bramon,Joseph D. Buxbaum,Anders D. Børglum,Anders D. Børglum,Sven Cichon,Sven Cichon,Ariel Darvasi,Enrico Domenici,Hannelore Ehrenreich,Tõnu Esko,Tõnu Esko,Tõnu Esko,Pablo V. Gejman,Michael Gill,Hugh Gurling,Christina M. Hultman,Nakao Iwata,Assen Jablensky,Erik G. Jönsson,Erik G. Jönsson,Kenneth S. Kendler,George Kirov,Jo Knight,Todd Lencz,Todd Lencz,Douglas F. Levinson,Qingqin S. Li,Jianjun Liu,Jianjun Liu,Anil K. Malhotra,Anil K. Malhotra,Steven A. McCarroll,Steven A. McCarroll,Andrew McQuillin,Jennifer L. Moran,Preben Bo Mortensen,Preben Bo Mortensen,Bryan J. Mowry,Markus M. Noethen,Roel A. Ophoff,Roel A. Ophoff,Michael John Owen,Aarno Palotie,Aarno Palotie,Aarno Palotie,Carlos N. Pato,Tracey L. Petryshen,Tracey L. Petryshen,Danielle Posthuma,Danielle Posthuma,Marcella Rietschel,Brien P. Riley,Dan Rujescu,Dan Rujescu,Pak C. Sham,Pamela Sklar,David St Clair,Daniel R. Weinberger,Jens R. Wendland,Thomas Werge,Thomas Werge,Mark J. Daly,Mark J. Daly,Patrick F. Sullivan,Patrick F. Sullivan,Michael Conlon O'Donovan +354 more